Targeted Therapy Resistance
Cross-source consensus on Targeted Therapy Resistance from 1 sources and 3 claims.
1 sources · 3 claims
Uses
How it works
Highlighted claims
- A central resistance problem is that blocking one oncogenic signaling component can be bypassed by alternative feedback cascades. — An Analytical Approach for Insulin-like Growth Factor Receptor 1 and Mammalian Target of Rapamycin Blockades in Ewing Sarcoma
- The study asks whether pathway fragility can be quantified and predicted to guide drug target combinations. — An Analytical Approach for Insulin-like Growth Factor Receptor 1 and Mammalian Target of Rapamycin Blockades in Ewing Sarcoma
- Drug target combinations are framed as a way to disrupt alternative signaling cascades responsible for Ewing sarcoma growth. — An Analytical Approach for Insulin-like Growth Factor Receptor 1 and Mammalian Target of Rapamycin Blockades in Ewing Sarcoma